Amid the growing use of weight loss medications, a new study has raised concerns about declining skeletal muscle health caused by the popular drugs.

In a recent commentary published in The Lancet journal, researchers from the US and Canada highlighted the critical importance of skeletal muscle mass in the context of medically induced weight loss, particularly with the widespread use of GLP-1 receptor agonists.